Total Payments
$6,255
2024 Payments
$2,262
Companies
36
Transactions
261
Medicare Patients
4,989
Medicare Billing
$806,446
Payment Breakdown by Category
Food & Beverage$6,204 (99.2%)
Education$50.69 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,204 | 257 | 99.2% |
| Education | $50.69 | 4 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,071 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $708.36 | 32 | $0 (2024) |
| Electromed, Inc. | $592.12 | 44 | $0 (2024) |
| Mylan Specialty L.P. | $581.02 | 23 | $0 (2024) |
| Genentech USA, Inc. | $417.40 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $294.27 | 14 | $0 (2024) |
| GENZYME CORPORATION | $263.06 | 7 | $0 (2024) |
| Amgen Inc. | $231.52 | 10 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $206.65 | 4 | $0 (2024) |
| Insmed, Inc. | $185.71 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,262 | 100 | AstraZeneca Pharmaceuticals LP ($429.25) |
| 2023 | $1,541 | 59 | GlaxoSmithKline, LLC. ($331.36) |
| 2022 | $808.78 | 39 | AstraZeneca Pharmaceuticals LP ($180.52) |
| 2021 | $222.64 | 15 | Electromed, Inc. ($70.14) |
| 2020 | $251.21 | 15 | Merck Sharp & Dohme Corporation ($96.58) |
| 2019 | $520.21 | 20 | Genentech USA, Inc. ($172.25) |
| 2018 | $370.02 | 10 | GlaxoSmithKline, LLC. ($125.00) |
| 2017 | $278.75 | 3 | Biofrontera Inc. ($143.87) |
All Payment Transactions
261 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: HFCWO | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Respiratory | ||||||
| 11/23/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: HFCWO | ||||||
| 11/22/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.77 | General |
| Category: HFCWO | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Philips North America LLC | (2383) SleepUndivided (Device) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Medical Device | ||||||
| 11/06/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/01/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/29/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/27/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $65.14 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $33.63 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $80.86 | General |
| Category: Immunology | ||||||
| 10/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.34 | General |
| Category: Immunology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,162 | 2,091 | $376,394 | $180,876 |
| 2022 | 17 | 1,198 | 1,997 | $295,671 | $173,316 |
| 2021 | 18 | 1,187 | 2,040 | $410,567 | $195,243 |
| 2020 | 14 | 1,442 | 2,329 | $715,869 | $257,011 |
Total Patients
4,989
Total Services
8,457
Medicare Billing
$806,446
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 320 | 764 | $136,705 | $69,633 | 50.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 233 | 479 | $56,852 | $28,739 | 50.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 78 | 138 | $57,132 | $22,401 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 209 | $40,337 | $20,525 | 50.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 84 | $22,636 | $10,990 | 48.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 70 | $18,270 | $9,001 | 49.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $8,300 | $4,090 | 49.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 24 | 28 | $10,808 | $2,732 | 25.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 44 | 46 | $3,772 | $1,990 | 52.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 40 | 42 | $3,570 | $1,810 | 50.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $3,136 | $1,560 | 49.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,761 | $1,377 | 49.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 13 | 14 | $2,534 | $1,151 | 45.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 45 | 51 | $2,091 | $1,085 | 51.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 32 | 34 | $1,972 | $1,059 | 53.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 11 | $2,101 | $1,026 | 48.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 31 | 35 | $1,785 | $897.27 | 50.3% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 31 | 34 | $1,632 | $810.24 | 49.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 359 | 744 | $95,232 | $58,868 | 61.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 96 | 177 | $61,596 | $30,038 | 48.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 206 | 398 | $35,422 | $22,114 | 62.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 133 | $21,546 | $13,256 | 61.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 89 | $20,114 | $12,925 | 64.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 83 | 84 | $20,748 | $12,460 | 60.1% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 89 | 106 | $11,978 | $7,595 | 63.4% |
About Dr. Mimi Phan, M.D
Dr. Mimi Phan, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1093035610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mimi Phan, M.D has received a total of $6,255 in payments from pharmaceutical and medical device companies, with $2,262 received in 2024. These payments were reported across 261 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,204).
As a Medicare-enrolled provider, Phan has provided services to 4,989 Medicare beneficiaries, totaling 8,457 services with total Medicare billing of $806,446. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Houston, TX
- Active Since 06/04/2010
- Last Updated 06/24/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093035610
Products in Payments
- SMARTVEST (Device) $592.12
- DUPIXENT (Biological) $522.09
- TEZSPIRE (Biological) $451.93
- YUPELRI (Drug) $448.25
- NUCALA (Biological) $384.07
- BREZTRI (Drug) $236.59
- AIRSUPRA (Drug) $236.35
- TRELEGY ELLIPTA (Drug) $225.44
- DAXXIFY (Drug) $206.65
- Arikayce (Drug) $185.71
- Xolair (Biological) $150.27
- CHARTIS CATHETER (Device) $146.04
- Ameluz (Drug) $143.87
- Yupelri (Drug) $132.77
- FASENRA (Biological) $129.54
- XARELTO (Drug) $129.17
- Avastin (Biological) $123.49
- Xhance (Drug) $115.63
- ZERBAXA (Drug) $112.08
- BOTOX (Biological) $111.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Internal Medicine $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Internal Medicine $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
Internal Medicine $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947
Internal Medicine $786,947